Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive
| Condition(s) | Cardiovascular Diseases, Lifestyle Factors |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive pharmacist support. To measure cardiovascular risk factors, the investigators are using the American Heart Association's Life's Essential 8 (LE8) factors-blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking. This study focuses on improving cardiovascular risk factors for individuals facing health disparities, such as ethnic minorities, limited English proficiency, and low-income groups. These groups are more likely to be seriously |
| Who can participate | Inclusion Criteria: * diagnosis of one or more of the following CV risk factors (i.e., hypertension, diabetes or hyperlipidemia); and * the risk factor is at poor or intermediate health levels as defined by LE8 (e.g., BP\>140/90 mm Hg); and * the patient exhibits poor adherence to prescribed medication to treat the CV risk factor as defined by a delay in refilling the medication within the past 6 months. Exclusion Criteria: * patients who do not have cellphone; or * enrolled in hospice or palliative care; or * Non-English or Spanish speaking; or * enrolled in another clinical trial if denoted in the EHR. |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Lead sponsor | University of Colorado, Denver |
| Locations | Denver, Colorado, United States; Fort Lupton, Colorado, United States; Wheat Ridge, Colorado, United States |
| Start date | 2024-02-26 |
| NCT ID | NCT06324981 |
| Official listing | https://clinicaltrials.gov/study/NCT06324981 |